by Clinical Neuropsychologist | Monday, May 27, 2024 | Dementia
Abstract INTRODUCTION While Latin America (LatAm) is facing an increasing burden of dementia due to the rapid aging of the population, it remains underrepresented in dementia research, diagnostics, and care. METHODS In 2023, the Alzheimer’s Association hosted...
by Clinical Neuropsychologist | Saturday, May 25, 2024 | Dementia
Abstract INTRODUCTION We explored how blood-brain barrier (BBB) leakage rate of gadolinium chelates (Ktrans) and BBB water exchange rate (kw) varied in cerebral small vessel disease (cSVD) subtypes. METHODS Thirty sporadic cSVD, 40 cerebral autosomal dominant...
by Clinical Neuropsychologist | Thursday, May 23, 2024 | Dementia
Abstract This perspective offers an alternative to the amyloid hypothesis in the etiology of Alzheimer’s disease (AD). We review evidence for a novel signaling mechanism based on a little-known peptide, T14. T14 could drive neurodegeneration as an aberrantly...
by Clinical Neuropsychologist | Thursday, May 23, 2024 | Dementia
Abstract INTRODUCTION Patients with subjective memory complaints (SMC) may include subgroups with different neuropsychological profiles and risks of cognitive impairment. METHODS Cluster analysis was performed on two datasets (n: 630 and 734) comprising demographic...
by Clinical Neuropsychologist | Thursday, May 23, 2024 | Dementia
Abstract INTRODUCTION We investigated the association of cognitive reserve (CR) with transitions across cognitive states and death. METHODS This population-based cohort study included 2631 participants (age ≥60 years) who were dementia-free at baseline and regularly...
by Clinical Neuropsychologist | Thursday, May 23, 2024 | Dementia
Abstract INTRODUCTION Tropomyosin related kinase B (TrkB) and C (TrkC) receptor signaling promotes synaptic plasticity and interacts with pathways affected by amyloid beta (Aβ) toxicity. Upregulating TrkB/C signaling could reduce Alzheimer’s disease (AD)-related...
